Isavuconazole for Treating Invasive Mould Disease in Solid Organ Transplant Recipients

Solid organ transplant (SOT) recipients have a higher risk of developing invasive mould diseases (IMD). Isavuconazole is a novel broad-spectrum azole active against Aspergillus spp. and Mucor, well tolerated, with an excellent bioavailability and predictable pharmacokinetics, that penetrates in most...

Full description

Bibliographic Details

Published in:	Transplant International
Main Authors:	Jose Tiago Silva, Shahid Husain, José María Aguado
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Subjects:	isavuconazole solid organ transplantation invasive mould disease invasive fungal infections invasive aspergillosis
Online Access:	https://www.frontierspartnerships.org/articles/10.3389/ti.2023.11845/full